Abstract: A method for treating, preventing or reducing the risk of joint destruction in a subject who suffers from a joint or musculoskeletal disease. The method comprises administering a histone deacetylase (HDAC) inhibitor or in conjunction with other agents to inhibit degradation and resorption of cartilage and bone in the joint.
Type:
Grant
Filed:
March 14, 2005
Date of Patent:
November 11, 2014
Assignee:
ASAN Laboratories Company (Cayman), Limited
Abstract: A method for preventing, treating, or ameliorating pruritus caused by skin, mucosa, or systemic disorder. The method comprises administering to a subject with pruritus or topically applying to an affected area with pruritus an effective amount of a formulation consisting essentially of a phenylbutyric acid or short-chain fatty acid derivative and a pharmaceutically acceptable carrier, salt or solvate thereof.
Type:
Grant
Filed:
August 31, 2007
Date of Patent:
September 30, 2014
Assignee:
Asan Laboratories Company (Cayman), Limited
Abstract: Disclosed are a composition and a method for treating skin disorders, including rosacea, pityriasis rosea, erythema, rhinophyma, and rosacea-associated disorders including pimples, papules, pustules, and telangiectasia.
Type:
Grant
Filed:
February 4, 2011
Date of Patent:
July 23, 2013
Assignee:
Asan Laboratories Company (Cayman), Limited
Abstract: Disclosed are a composition and a method for treating skin disorders, including rosacea, pityriasis rosea, erythema, rhinophyma, and rosacea-associated disorders including pimples, papules, pustules, and telangiectasia.
Type:
Application
Filed:
February 4, 2011
Publication date:
September 1, 2011
Applicant:
Asan Laboratories Company (Cayman), Limited